Northern Trust’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
Other funds holding KLRS
SL
Northern Trust's KLRS Position: Q3 2026 in Review
Northern Trust reduced its Kalaris Therapeutics (KLRS) stake by 0.02% in Q3 2026, selling an estimated $23 and leaving 25,833 shares worth $74.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4164.
Northern Trust first reported a position in KLRS in Q3 2020 and has held it in 22 quarters since. The position peaked at $8.19M in Q4 2020. 54 funds tracked by Wall St. Rank hold KLRS as of Q3 2026.
- Northern Trust held 25,833 shares of Kalaris Therapeutics worth $74.7K as of Q3 2026.
- Northern Trust sold 6 Kalaris Therapeutics shares in Q3 2026, an estimated $23.
- Kalaris Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #4164 holding.
- Northern Trust first reported a position in Kalaris Therapeutics in Q3 2020 and has held it in 22 quarters since.
- Northern Trust's Kalaris Therapeutics position peaked at $8.19M in Q4 2020.
- 54 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.